Literature DB >> 925879

A pharmacokinetic model for high-dose methotrexate infusions in man.

S D Reich, N R Bachur, R H Goebel, M Berman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 925879     DOI： 10.1007/bf01061726

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  14 in total

1.  Kinetic model for the disposition and metabolism of moderate and high-dose methotrexate (NSC-740) in man.

Authors:  P R Leme; P J Creaven; L M Allen; M Berman
Journal:  Cancer Chemother Rep       Date:  1975 Jul-Aug

2.  Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.

Authors:  N Jaffe
Journal:  Cancer Chemother Rep       Date:  1974 Mar-Apr

3.  Improved therapeutic index of methotrexate with "leucovorin rescue".

Authors:  M Levitt; M B Mosher; R C DeConti; L R Farber; R T Skeel; J C Marsh; M S Mitchell; R J Papac; E D Thomas; J R Bertino
Journal:  Cancer Res       Date:  1973-07       Impact factor: 12.701

4.  Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors.

Authors:  C B Pratt; D Roberts; E C Shanks; E L Warmath
Journal:  Cancer Res       Date:  1974-12       Impact factor: 12.701

5.  Comparative studies on the transport of aminopterin, methotrexate, and methasquin by the L1210 leukemia cell.

Authors:  F M Sirotnak; R C Donsbach
Journal:  Cancer Res       Date:  1972-10       Impact factor: 12.701

6.  Pharmacokinetics of methotrexate.

Authors:  D H Huffman; S H Wan; D L Azarnoff; B Hogstraten
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

7.  Methotrexate pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick; D S Zaharko; J A Longstreth
Journal:  J Pharm Sci       Date:  1971-08       Impact factor: 3.534

8.  Methotrexate tissue distribution: prediction by a mathematical model.

Authors:  D S Zaharko; R L Dedrick; K B Bischoff; J A Longstreth; V T Oliverio
Journal:  J Natl Cancer Inst       Date:  1971-04       Impact factor: 13.506

9.  The kinetics of methotrexate distribution in spontaneous canine lymphosarcoma.

Authors:  R J Lutz; R L Dedrick; J A Straw; M M Hart; P Klubes; D S Zaharko
Journal:  J Pharmacokinet Biopharm       Date:  1975-04

10.  7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate.

Authors:  S A Jacobs; R G Stoller; B A Chabner; D G Johns
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808
View more
  8 in total

1.  Nonlinear renal elimination kinetics of methotrexate due to saturation of renal tubular reabsorption.

Authors:  J Hendel; A Nyfors
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 2.  Dose-dependent pharmacokinetics and cancer chemotherapy.

Authors:  G Powis; M M Ames; J S Kovach
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

3.  Rapid plasma clearance and reduced rate and extent of urinary elimination of parenterally administered methotrexate as a result of severe vomiting and diarrhoea.

Authors:  H W Van Den Berg; R F Murphy; D G Kennedy
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

4.  Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits.

Authors:  H Iven; H Brasch; J Engster
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

5.  Mathematical modeling -- guide to high-dose methotrexate infusion therapy.

Authors:  S D Reich
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

6.  Renal clearance of methotrexate in man during high-dose oral and intravenous infusion therapy.

Authors:  N Christophidis; W J Louis; I Lucas; W Moon; F J Vajda
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

7.  Change in transfer rate of methotrexate from spinal fluid to plasma during intrathecal therapy in children and adults.

Authors:  J Lankelma; R J Lippens; A Drenthe-Schonk; E F Termond; E van der Kleijn
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

8.  Dose dependent methotrexate elimination following bolus intravenous injection.

Authors:  J R Lawrence; W H Steele; J F Stuart; C A McNeill; J G McVie; B Whiting
Journal:  Eur J Clin Pharmacol       Date:  1980-05       Impact factor: 2.953
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.